Skip to main content
Pharming Group N.V. logo

Pharming Group N.V. — Investor Relations & Filings

Ticker · PHARM ISIN · NL0010391025 LEI · 724500DCJ9MPG74JEH91 AS Manufacturing
Open in API
Filings indexed 802 across all filing types
Latest filing 2007-05-23 AGM Information
Country NL Netherlands
Listing AS PHARM

About Pharming Group N.V.

https://www.pharming.com/

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.

Recent filings

Filing Released Lang Actions
Pharming provides business update at shareholders' meeting
AGM Information Classification · 98% confidence The document is titled with an update given during the 'algemene vergadering van aandeelhouders' (Annual General Meeting or AGM). It explicitly states that management will give a presentation ('presentatie geven') about product and business development progress during this meeting. The content details operational updates (Rhucin® registration status, FDA discussions, new advisory board) which are typical components of an AGM presentation or update provided to shareholders at that event. This aligns perfectly with the definition of 'AGM Information' (Code: AGM-R). It is not a full 10-K, a standalone AR, or just an ER; it is material presented *at* the AGM.
2007-05-23 English
Pharming provides business update at shareholders' meeting
AGM Information Classification · 98% confidence The document explicitly states that the company will 'present an update of its business at the Annual General Meeting of Shareholders in Leiden'. The content details business progress, product development updates (Rhucin®), corporate developments, and announcements regarding future events (R&D day). This content is directly related to the proceedings and materials shared during an Annual General Meeting (AGM). Therefore, the most appropriate classification is AGM Information (AGM-R).
2007-05-23 English
Pharming proposes new members for Supervisory Board
Board/Management Information Classification · 98% confidence The document is a press release announcing the nomination of new members for the Supervisory Board (Raad van Commissarissen) to be voted on during the upcoming Annual General Meeting (algemene vergadering van aandeelhouders). This content directly relates to changes in the company's board of directors/supervisory body. This aligns perfectly with the definition for Board/Management Information (MANG). Although it mentions the AGM, the primary focus is the board composition change, not the AGM materials themselves (AGM-R) or the voting results (DVA).
2007-05-08 English
Pharming proposes new members for Supervisory Board
Board/Management Information Classification · 99% confidence The document is a press release announcing proposed changes to the Supervisory Board to be voted upon at the upcoming Annual General Meeting (AGM) on May 23, 2007. It explicitly mentions the 'Annual General Meeting of Shareholders' and the proposal of new members. While it mentions that the 'Annual Report' will be available at the meeting, the primary subject and purpose of this specific document is the announcement regarding the board changes and the AGM agenda items. This strongly aligns with the 'Board/Management Information' (MANG) category, as it details changes to the board structure. It is not the AGM presentation itself (AGM-R), nor is it a formal proxy statement (PSI), but rather an announcement preceding the meeting regarding board composition.
2007-05-08 English
Pharming announces first quarter 2007 results
Interim / Quarterly Report Classification · 100% confidence The document is a press release announcing the first quarter (Q1) 2007 financial results for Pharming Group NV. It includes a summary of key developments, management commentary, and detailed financial statements (Consolidated Balance Sheet, Income Statement, and Cash Flow). Since it provides comprehensive financial data for a period shorter than a full fiscal year (Q1), it is classified as an Interim/Quarterly Report. Q1 2007
2007-04-20 English
Pharming announces first quarter 2007 results
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial results announcement for Pharming Group NV for the period ending March 31, 2007. It contains a narrative summary of financial and operational developments, followed by consolidated financial statements (Balance Sheet, Income Statement, and Cash Flow). Because it provides comprehensive financial data for a period shorter than a full fiscal year (Q1), it fits the definition of an Interim/Quarterly Report (IR). Q1 2007
2007-04-20 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.